鵬翎股份(300375.SZ):預計2023年尼龍管產品收入佔流體管路產品收入的30%左右
格隆匯6月13日丨鵬翎股份(300375.SZ)接受機構調研、現場參觀,互動交流環節中,就“公司一季度業績情況出現下滑,是否有分析?公司尼龍管產品情況如何?”
公司回覆稱,公司生產經營一切正常,密封件業務受益於長安汽車產銷量穩定以及比亞迪新項目轉產的影響,2023年一季度銷售收入保持穩中有增的趨勢;流體管路業務部分客户銷量不及預期(如上汽大眾銷量下滑較多),2023年一季度銷售收入出現一定下滑。
公司流體管路業務中的尼龍管產品保持穩中有增的趨勢,預計2023年尼龍管產品收入佔流體管路產品收入的30%左右。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.